my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
05-09-2006: The Irish National Institute for Bioprocessing Research and Training (NIBRT) and Organon, the human healthcare business of Akzo Nobel, announced the formation of a research collaboration which will focus on the control and understanding of glycosylation in CHO cell culture. The collaboration is designed to combine NIBRT's academic resources with the existing manufacturing know-how of Organon to improve the control of the cell culture process.
The research program will study the regulation and expression of those enzymes active in cell cultures which are highly relevant for their role in glycosylation. Using a combination of systems biology modelling and experimental validation in vitro, key optimisation data will be generated under the collaboration which will advance the understanding of glycosylation-related enzyme expression, regulation and action in production systems. The research will move from computational prediction and wetlab experiment through to up-scaled cell culture bioreactors for reduction to practice.
According to the company, this is the first industry research collaboration to be announced by NIBRT, which was incorporated early in 2006. The academic portion of the collaboration will be supported by Prof. Keith Tipton and Dr. Gavin Davey of the Systems Biology Group in the School of Biochemistry and Immunology, Trinity College Dublin (TCD). Experimental work will be carried out in TCD and later in collaboration with Prof. Pauline Rudd's group (NIBRT) in Belfield. Scale-up work will be carried out in the new NIBRT research facility, currently under construction.
This collaboration is targeted as a multi-annual research programme with associated milestones and will be reviewed and directed by the programme team on a continual basis. The programme costs for the collaboration will be shared by NIBRT and Organon.
Watchlist
This is where you can add this news to your personal favourites
AkzoNobel acquires pioneering plant-based separation technology
AkzoNobel has boosted its technology portfolio in sustainable chemistry after agreeing to acquire from Integrated Botanical Technologies (IBT) its patented Zeta Fraction(TM) technology, which is transforming how plant-based chemistry is used. Financial details were not disclosed.The unique ... more
Akzo Nobel N.V. has completed the sale of Organon BioSciences N.V. to Schering-Plough Corporation for EUR 11 billion. Confirmation of the completion of the transaction comes after Schering-Plough received all the necessary approvals, including clearance from the U.S. Federal Trade Commissio ... more
Organon, the human healthcare business unit of Akzo Nobel, announced that it has signed an exclusive, worldwide license agreement with Endotis Pharma concerning the development and commercialization of several antithrombotic compounds. Endotis is a specialty pharma company dedicated to the ... more
Akzo Nobel Industrial Chemicals GmbH
Manufacturer and worldwide distributor of bulk-quantities of methyl chloride, methylene chloride (dichlormethane), chloroform, hydrochloric acid, caustic soda solution and microprills, CaCl2-solution, NaOCl-solution and chlorine. more
Akzo Nobel N.V. has completed the sale of Organon BioSciences N.V. to Schering-Plough Corporation for EUR 11 billion. Confirmation of the completion of the transaction comes after Schering-Plough received all the necessary approvals, including clearance from the U.S. Federal Trade Commissio ... more
Organon, the human healthcare business unit of Akzo Nobel, announced that it has signed an exclusive, worldwide license agreement with Endotis Pharma concerning the development and commercialization of several antithrombotic compounds. Endotis is a specialty pharma company dedicated to the ... more
European expert consortium combines forces to develop a novel pandemic influenza vaccine
A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The four-year project has been awarded a grant of EUR3.5 million from the European Union to help fund t ... more
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core the ... more
The Irish National Institute for Bioprocessing Research and Training (NIBRT) and Organon, the human healthcare business of Akzo Nobel, announced the formation of a research collaboration which will focus on the control and understanding of glycosylation in CHO cell culture. The collaboratio ... more
National Institute for Bioprocessing Research and Training (NIBRT)
The National Institute for Bioprocessing Research and Training (NIBRT) is a world-class institute that provides training and research solutions for the bioprocessing industry in state of the art facilities. NIBRT is located in Dublin, Ireland and is based on an innovative collaboration bet ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
